Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian G Reich

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Biomedical Informatics|June 26, 2019
HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data modelJeremy L Warner, Dmitry Dymshyts, Christian G Reich, et al.
Journal of Neurophysiology|April 25, 2014
Evidence of calcium-permeable AMPA receptors in dendritic spines of CA1 pyramidal neuronsHayley A Mattison, Ashish A Bagal, Michael Mohammadi, et al.
Drug Safety|October 30, 2013
A comparison of the empirical performance of methods for a risk identification systemPatrick B Ryan, Paul E Stang, J Marc Overhage, et al.
Pharmacoepidemiology and Drug Safety|July 16, 2016
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome associationSusan Gruber, Aloka Chakravarty, Susan R Heckbert, et al.
Lancet (London, England)|November 1, 2019
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysisMarc A Suchard, Martijn J Schuemie, Harlan M Krumholz, et al.
Journal of Medical Internet Research|March 27, 2019
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective StudySeo Jeong Shin, Seng Chan You, Yu Rang Park, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2021
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort StudyRuiJun Chen, Marc A Suchard, Harlan M Krumholz, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systemsCarlos Bell, Aloka Chakravarty, Susan Gruber, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2021
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational StudySeng Chan You, Harlan M Krumholz, Marc A Suchard, et al.
JAMA|October 27, 2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionSeng Chan You, Yeunsook Rho, Behnood Bikdeli, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Biomedical Informatics|June 26, 2019
HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data modelJeremy L Warner, Dmitry Dymshyts, Christian G Reich, et al.
Journal of Neurophysiology|April 25, 2014
Evidence of calcium-permeable AMPA receptors in dendritic spines of CA1 pyramidal neuronsHayley A Mattison, Ashish A Bagal, Michael Mohammadi, et al.
Drug Safety|October 30, 2013
A comparison of the empirical performance of methods for a risk identification systemPatrick B Ryan, Paul E Stang, J Marc Overhage, et al.
Pharmacoepidemiology and Drug Safety|July 16, 2016
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome associationSusan Gruber, Aloka Chakravarty, Susan R Heckbert, et al.
Lancet (London, England)|November 1, 2019
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysisMarc A Suchard, Martijn J Schuemie, Harlan M Krumholz, et al.
Journal of Medical Internet Research|March 27, 2019
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective StudySeo Jeong Shin, Seng Chan You, Yu Rang Park, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2021
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort StudyRuiJun Chen, Marc A Suchard, Harlan M Krumholz, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systemsCarlos Bell, Aloka Chakravarty, Susan Gruber, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2021
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational StudySeng Chan You, Harlan M Krumholz, Marc A Suchard, et al.
JAMA|October 27, 2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionSeng Chan You, Yeunsook Rho, Behnood Bikdeli, et al.
Pageof 5